Real-time enrollment status for this chronic inflammatory demyelinating polyneuropathy clinical trial
Current Status
Recruiting
Checked: November 12, 2026 at 9:55 AM UTC
| NCT Number | NCT07091630 |
| Recruiting Status | Recruiting |
| Condition | Chronic Inflammatory Demyelinating Polyneuropathy |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 14 sites in the US |
| Sponsor | argenx |
| Last Updated on CT.gov | November 9, 2026 (3 days ago) |
As of November 12, 2026: Clinical trial NCT07091630 is currently recruiting participants. This phase3 study for chronic inflammatory demyelinating polyneuropathy is actively seeking new participants at 14 locations across the United States. The study is sponsored by argenx. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07091630 is actively recruiting participants as of November 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07091630 was last updated 3 days ago (November 9, 2026). HelloStudys verifies this status automatically.